| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,674 |
15,073 |
$2.30M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,044 |
5,354 |
$1.37M |
| 87501 |
|
1,635 |
1,610 |
$67K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,553 |
1,525 |
$62K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,904 |
1,849 |
$60K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
336 |
331 |
$40K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,525 |
1,376 |
$32K |
| 87430 |
|
1,832 |
1,787 |
$26K |
| 71046 |
Radiologic examination, chest; 2 views |
280 |
273 |
$24K |
| 85027 |
|
5,666 |
5,100 |
$23K |
| 71045 |
Radiologic examination, chest; single view |
807 |
760 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,656 |
1,612 |
$21K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
618 |
559 |
$18K |
| 80053 |
Comprehensive metabolic panel |
1,475 |
1,344 |
$17K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,531 |
1,420 |
$16K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
153 |
111 |
$8K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
52 |
52 |
$8K |
| 81001 |
|
1,438 |
1,397 |
$4K |
| 81003 |
|
2,020 |
1,895 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
497 |
437 |
$3K |
| 76801 |
|
27 |
25 |
$3K |
| 70450 |
Computed tomography, head or brain; without contrast material |
47 |
46 |
$2K |
| 80076 |
|
259 |
247 |
$1K |
| 83690 |
|
419 |
396 |
$1K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
14 |
13 |
$1K |
| 84703 |
|
238 |
232 |
$1K |
| 81025 |
|
166 |
159 |
$1K |
| 84484 |
|
341 |
276 |
$674.13 |
| 86403 |
|
76 |
74 |
$653.05 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
75 |
61 |
$599.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
30 |
30 |
$596.54 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
43 |
42 |
$572.50 |
| 82248 |
|
222 |
205 |
$348.56 |
| 86308 |
|
57 |
55 |
$187.75 |
| 83880 |
|
13 |
13 |
$164.90 |
| 84702 |
|
15 |
13 |
$151.68 |
| 86901 |
|
32 |
32 |
$45.43 |
| 86900 |
|
32 |
32 |
$45.43 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
46 |
40 |
$42.46 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
14 |
12 |
$40.68 |
| 85610 |
|
31 |
28 |
$18.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
14 |
12 |
$4.76 |
| A9270 |
Non-covered item or service |
197 |
94 |
$0.00 |
| J3490 |
Unclassified drugs |
28 |
25 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
12 |
12 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
37 |
37 |
$0.00 |